Retrospective study of 56 cases with Hodgkin lymphoma

吴维颢,程志祥,王伟光,袁玲,庄静丽,李天舒,李锋,邹善华,徐建民

DOI: https://doi.org/10.13201/j.issn.1004-2806.2012.02.005

2012-01-01

Abstract:Objective:To summarize the clinical features and therapeutic outcomes,and to analyze risk factors affecting response and survival in 56 patients with Hodgkin lymphoma(HL).Method:We reviewed datas retrospectively from 56 patients,receiving ABVD as initial regimen.Those resistant to primary therapy or relapsed were treated with second-line regimens.Radiotherapy were performed according to NCCN guideline.Responses and adverse effects were assessed at the completion of treatment.We analysed risk factors affecting outcome by using statistical software SPSS17.0.Result:HL accounted for 7.6% of total newly diagnosed lymphomas in the corresponding period,patients younger than 40 years old constituted 53.6% of the total,no bimodal age distribution was observed.Pathological study revealed that 100% were classical Hodgkin lymphoma,nodular sclerosing and mixed cellularity accounted for 89.2% with a ratio of 1∶1.Pre-treatment evaluation showed that 71.4% of the patients were in stage Ⅲor Ⅳ,and 60% were with B symptoms.12.5% had bulky disease.Lymph nodes in mediastinum,neck and axillaries were most likely involved,24 patients(42.9%)presented with extra nodal tissues involvement,of which 11 patients had osseous involvement,10 patients had lungs infiltrated.Fouty-seven patients were assessable for responses and adverse effects at the completion of treatment,complete remission rate was 68.1%,partial remission 6.4%,stable disease 14.9%,disease progression 10.6%.Grade 3 neutropenia and pulmonary toxicity occurred in 3 cases respectively.At 34 months median follow-up,there were 6 deaths and 5 relapses.Two-year and 3-year disease free survival rates and overall survival rates were 76.5%,60.0%;85.3%,75.0% respectively.Conclusion:To identify young patients who are at high risk of poor prognosis more early and to treat them with more intensive chemotherapy,meanwhile monitor toxicity more carefully,survival of HL could be further improved.